Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-06-19 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
独立董事关于第三届董事会第九次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a specific board meeting decision regarding the waiver of a preemptive purchase right related to a subsidiary's equity. It references compliance with regulatory rules and company bylaws, and it is signed by independent directors. The content is focused on board/management matters rather than financial results, audit, or shareholder voting results. The document length is short (881 characters) and does not contain financial statements or earnings data. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management opinions.
2017-06-19 Chinese
第三届董事会第九次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the ninth meeting of the third board of directors of the company. It details the meeting date, attendance, the agenda item about waiving the preemptive purchase rights on subsidiary shares, and the voting results. There is no financial data, no report publication, no regulatory certification, or other report types. This is a clear announcement of board meeting decisions, specifically about corporate governance and shareholder rights. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board resolutions, not a full report or financial statement.
2017-06-19 Chinese
关于公司股权激励计划全部剩余股票期权与限制性股票回购注销完成的公告
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement regarding the completion of the company's stock option and restricted stock repurchase and cancellation under its equity incentive plan. It includes specific numbers of shares and options canceled, reasons for cancellation based on performance criteria, board meeting approvals, and adjustments to share capital. The document is a formal announcement of a corporate action related to share repurchase and cancellation of equity incentives, not a full financial report or earnings release. It does not contain comprehensive financial statements or quarterly/annual financial results. The content fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or cancellations of its own shares or stock options.
2017-06-14 Chinese
关于重大资产重组进展暨延期复牌的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of a major asset restructuring and the extension of a trading suspension (停牌) due to this restructuring. It mentions ongoing work such as due diligence, audit, and evaluation related to the asset restructuring, and states that the company cannot disclose the restructuring plan by the originally scheduled date. It also states the stock will remain suspended until the plan is disclosed. This is a clear update on a capital/financing event (major asset restructuring) and trading status, not a full report or financial statement. The document length is short (857 characters) and it is an announcement of progress and suspension extension, not a full report or detailed financial data. Therefore, it fits best under Capital/Financing Update (CAP).
2017-06-14 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of a major asset restructuring. It mentions stock suspension due to the ongoing major asset reorganization and references previous announcements about the progress. The document does not contain financial statements or detailed financial data but is an update on the status of a significant corporate transaction. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings. The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is CAP with high confidence.
2017-06-07 Chinese
北京国枫律师事务所关于公司2017年限制性股票激励计划调整授予限制性股票相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding adjustments to a 2017 restricted stock incentive plan for a company. It discusses legal compliance, authorization, and approval of stock grant adjustments. It is not a financial report, earnings release, or regulatory filing per se, but a legal opinion related to a capital incentive plan. The document length is short (2543 characters) and it is a standalone legal opinion letter, not a report or announcement of a report. This fits best under Regulatory Filings (RNS) as it is a legal compliance document that does not fit other categories like Capital/Financing Update or Share Issue/Capital Change because it is a legal opinion rather than an announcement or update of financing or capital changes.
2017-06-02 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.